Case Comprehensive Cancer Center

Nathan Berger has produced decades of biomedical research into cancer development and its associated risk factors. He is a nationally renowned authority on hematology and oncology and founding member of the Case Comprehensive Cancer Center, a consortium between Case Western Reserve, University…

The Case Comprehensive Cancer Center (Case CCC) recently announced it received a $2 million grant through the Alliance for Equity in Cancer Care (the Alliance), an initiative funded by the Merck Foundation (the Foundation) and designed to make cancer care more equitable in the United States by…

September is National Sickle Cell Awareness Month, which aims to bring attention to advancing research, care practices, treatments and possible cures for people with sickle cell disease. Umut Gurkan To better understand this blood disorder, The Daily sat down with Umut Gurkan, a professor in the…

Researchers say pathway is linked to tumor development Research led by Case Western Reserve University has identified a promising path to developing therapies to treat esophageal tumors—a form of cancer that not only is among the most deadly, but also has been occurring at increasing rates over…

Stanton Gerson, dean of the School of Medicine, shared his view on why 2022 is a breakthrough year in our battle against cancer in an op-ed published by Crain’s Cleveland Business. Titled “Personal View: A breakthrough year in the war on cancer,” Gerson’s piece described the role the Case…

“Brilliant,” “dedicated” and “wonderful” are just a few of the words being used to describe revered Case Western Reserve University School of Medicine faculty member Chris G. Dealwis, who passed away unexpectedly last weekend while visiting family in England. As a scientist, Dealwis’…

Researchers at Case Western Reserve, University of Washington working to gain novel view of cancer, supported by $3.1 million National Institutes of Health grant Researchers at Case Western Reserve University and the University of Washington expect to gain valuable new insights into highly…

Case Western Reserve University and University Hospitals research team publishes new findings in Nature Cancer A drug used to target IDH1 mutations in select cancers also appears to inhibit the wild-type form of the enzyme, under certain conditions. This feature explains why a large group of…

Data support PSA screening, particularly in Black men, for whom there is a shortage of clinical trial evidence Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening…

The 6th annual Cancer Disparities Symposium, hosted by Case Comprehensive Cancer Center, will take place from Thursday, March 3, through Friday, March 4. The symposium will be in a virtual format. "Racism, Poverty and Biology and the Intersection with Cancer Screenings, Diagnosis and Treatment" is…